Recurrent Acute Biphenotypic Leukemia Suspended Phase 1 Trials for Fludarabine (DB01073)
Also known as: Acute, recurrent Biphenotypic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia) | Suspended | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03326921 | HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant | Treatment |